Cargando…

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance

AIMS: No consensus exists on the clinical value of tumour regression grading (TRG) systems for therapy effects of neoadjuvant chemoradiotherapy (nCRT) in oesophageal adenocarcinoma. Existing TRG systems lack standardization and reproducibility, and do not consider the morphological heterogeneity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graham Martinez, Cristina, Kus Öztürk, Sonay, Al‐Kaabi, Ali, Valkema, Maria J, Bokhorst, John‐Melle, Rosman, Camiel, Rütten, Heidi, Wauters, Carla A P, Doukas, Michail, van Lanschot, Joseph Jan‐Baptist, Siersema, Peter D, Nagtegaal, Iris D, van der Post, Rachel Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325353/ https://www.ncbi.nlm.nih.gov/pubmed/35352847 http://dx.doi.org/10.1111/his.14644

Ejemplares similares

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
por: Valkema, Maria J, et al.
Publicado: (2023)

Predicting lymph node metastases with endoscopic resection in cT2N0M0 oesophageal cancer: A systematic review and meta-analysis
por: Al-Kaabi, Ali, et al.
Publicado: (2019)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
por: Valkema, Maria J., et al.
Publicado: (2023)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
por: Noordman, Bo Jan, et al.
Publicado: (2018)

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
por: Eyck, Ben M., et al.
Publicado: (2021)

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2
por: van der Zijden, Charlène J., et al.
Publicado: (2023)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study
por: Hermus, Merel, et al.
Publicado: (2022)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
por: van der Wilk, B. J., et al.
Publicado: (2020)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2006)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score
por: Ubels, Sander, et al.
Publicado: (2022)

Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma
por: Jiang, William, et al.
Publicado: (2022)

Metastatic pattern in esophageal and gastric cancer: Influenced by site and histology
por: Verstegen, Moniek HP, et al.
Publicado: (2020)

Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports
por: Baranov, Nikolaj S., et al.
Publicado: (2019)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study
por: Ubels, Sander, et al.
Publicado: (2023)

Extent and consequences of lymphadenectomy in oesophageal cancer surgery: case vignette survey
por: de Gouw, Didi JJM, et al.
Publicado: (2020)

Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison
por: Eyck, Ben M, et al.
Publicado: (2022)

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: Hagens, E. R. C., et al.
Publicado: (2020)

Deep learning for multi-class semantic segmentation enables colorectal cancer detection and classification in digital pathology images
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Systematic review with meta‐analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma
por: Peters, Yonne, et al.
Publicado: (2021)

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
por: Boonstra, Jurjen J, et al.
Publicado: (2011)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Staging investigations for oesophageal cancer: a meta-analysis
por: van Vliet, E P M, et al.
Publicado: (2008)

Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy
por: Knight, W. R. C., et al.
Publicado: (2018)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

On Reverse Shrinkage Effects and Shrinkage Overshoot
por: Jordan, Pascal
Publicado: (2022)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
por: Scholte, Mirre, et al.
Publicado: (2020)

Study protocol for the nutritional route in oesophageal resection trial: a single-arm feasibility trial (NUTRIENT trial)
por: Weijs, Teus J, et al.
Publicado: (2014)

Management of intrathoracic and cervical anastomotic leakage after esophagectomy for esophageal cancer: a systematic review
por: Verstegen, Moniek H. P., et al.
Publicado: (2019)

Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial
por: van Vulpen, J K, et al.
Publicado: (2021)

Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer
por: Lavery, Anita, et al.
Publicado: (2021)

The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients
por: Graham Martínez, Cristina, et al.
Publicado: (2022)

Meta-Analysis of Shrinkage Mode After Neoadjuvant Chemotherapy for Breast Cancers: Association With Hormonal Receptor
por: Zheng, Chun-Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3necda4mr458nfmj870mf18v2